Glaukos Corporation
GKOS
$237.31-0.79 (0.33%)Nov 20
After-hours: $237.31 (+0.00%)
Glaukos Corporation (GKOS)
$237.31-0.79-0.33%Nov 20
Loading chart…
YTD110%
M.cap.14.0 bn
Std.Dev, 1y2.59
Vol, bn0.3 (high)
RSI49
P/E371.5
MFI31
P/S18.73
ADX51 (trend)
P/B19.59
Beta0.70
Div—
Debt/EBITDA—
Payout—
Price target
Buy 13 (93%)Hold 1 (7%)Sell 0 (0%)
Next earnings16 Feb, after close
Earnings surprise
Short interest7.9% (+0.2%), 30 Oct 2026
Fund owners #339 (-55)
Insider ownership$776 mm
Insider sellingVery High
Insider buying—
General
M.Cap$14.0B
Dividends—
Next report16 Feb, after close
Forecast
Valuation
Target
P/E371.5
P/S18.73
P/B19.59
Fundamentals
5-y avg sales growth+17.7%
Debt / EBITDA0.00
ROE—
Altman Z-score15.61 (safe)
Technicals
RSI49
MFI31
Price / MA50+24.3% (v.high) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

Glaukos Corporation develops innovative treatments for glaucoma, corneal disorders, and retinal diseases. Their products include micro-bypass stents inserted during cataract surgery and targeted injectable implants for delivering medication. Based in San Clemente, California, they sell their products directly and through distributors both in the US and worldwide.

WikipediaHeadcount: 1,094
Address:One Glaukos Way, Aliso Viejo, CA, United States, 92656
About

Glaukos Corporation develops innovative treatments for glaucoma, corneal disorders, and retinal diseases. Their products include micro-bypass stents inserted during cataract surgery and targeted injectable implants for delivering medication. Based in San Clemente, California, they sell their products directly and through distributors both in the US and worldwide.

https://www.glaukos.com
Beta 0.70